Randomized Phase III Trial of Haploidentical HCT with or without an Add back Strategy of HSV-Tk Donor Lymphocytes in Patients with High Risk Acute Leukemia - Regional Cancer Care Associates LLC

Clinical Trials

Randomized Phase III Trial of Haploidentical HCT with or without an Add back Strategy of HSV-Tk Donor Lymphocytes in Patients with High Risk Acute Leukemia

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
MolMed
Protocol Number
TK008
Cancer Diagnosis
To Learn More Call
201-510-0910